Total Payments
$6,937
2024 Payments
$972.07
Companies
32
Transactions
385
Medicare Patients
1,545
Medicare Billing
$184,179
Payment Breakdown by Category
Food & Beverage$6,937 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,937 | 385 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $841.68 | 46 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $729.93 | 49 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $630.92 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $578.16 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $538.27 | 36 | $0 (2024) |
| PFIZER INC. | $498.68 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $429.75 | 20 | $0 (2023) |
| Shionogi Inc | $273.74 | 12 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $258.00 | 7 | $0 (2024) |
| Allergan Inc. | $251.81 | 11 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $972.07 | 42 | Ferring Pharmaceuticals Inc. ($153.81) |
| 2023 | $938.70 | 44 | Alexion Pharmaceuticals, Inc. ($216.35) |
| 2022 | $1,013 | 53 | AstraZeneca Pharmaceuticals LP ($211.75) |
| 2021 | $679.34 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($145.60) |
| 2020 | $251.34 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($52.82) |
| 2019 | $850.54 | 55 | Merck Sharp & Dohme Corporation ($120.65) |
| 2018 | $1,224 | 77 | Janssen Pharmaceuticals, Inc ($255.80) |
| 2017 | $1,008 | 66 | Janssen Pharmaceuticals, Inc ($183.78) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.41 | General |
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: ANTIBIOTICS | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $35.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.74 | General |
| 10/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/27/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Infections and Infectious Diseases | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.71 | General |
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Gastroenterology | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.56 | General |
| 08/22/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: HEMATOLOGY | ||||||
| 08/15/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Rare Disease | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.13 | General |
| 07/18/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 257 | 436 | $92,233 | $30,509 |
| 2022 | 3 | 315 | 610 | $97,399 | $40,732 |
| 2021 | 4 | 491 | 773 | $107,750 | $55,570 |
| 2020 | 4 | 482 | 812 | $112,160 | $57,368 |
Total Patients
1,545
Total Services
2,631
Medicare Billing
$184,179
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 147 | 306 | $56,974 | $18,698 | 32.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 68 | $18,202 | $6,218 | 34.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 61 | 62 | $17,056 | $5,594 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 140 | 345 | $44,516 | $19,355 | 43.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 110 | 199 | $38,732 | $16,193 | 41.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 65 | 66 | $14,152 | $5,184 | 36.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 215 | 406 | $46,690 | $24,037 | 51.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 183 | 273 | $43,680 | $23,753 | 54.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 74 | 75 | $14,625 | $6,592 | 45.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 19 | 19 | $2,755 | $1,189 | 43.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 206 | 441 | $50,715 | $25,748 | 50.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 185 | 280 | $44,800 | $24,158 | 53.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 69 | 69 | $13,455 | $6,089 | 45.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 22 | 22 | $3,190 | $1,373 | 43.0% |
About Dr. Radha Yalamanchili, MD
Dr. Radha Yalamanchili, MD is a Hospitalist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942230214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Radha Yalamanchili, MD has received a total of $6,937 in payments from pharmaceutical and medical device companies, with $972.07 received in 2024. These payments were reported across 385 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,937).
As a Medicare-enrolled provider, Yalamanchili has provided services to 1,545 Medicare beneficiaries, totaling 2,631 services with total Medicare billing of $184,179. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Dallas, TX
- Active Since 07/03/2006
- Last Updated 11/05/2007
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1942230214
Products in Payments
- XARELTO (Drug) $841.68
- ELIQUIS (Drug) $840.87
- XIFAXAN (Drug) $485.32
- LOKELMA (Drug) $429.75
- DIFICID (Drug) $391.01
- JARDIANCE (Drug) $380.99
- Fetroja (Drug) $273.74
- ULTOMIRIS (Biological) $237.44
- Veltassa (Drug) $222.44
- ENTRESTO (Drug) $212.62
- Kcentra (Biological) $210.80
- CHANTIX (Drug) $197.09
- REBYOTA (Biological) $153.81
- RELISTOR (Drug) $145.60
- AVYCAZ (Drug) $138.06
- Caldolor (Drug) $136.88
- PRADAXA (Drug) $132.72
- TEFLARO (Drug) $113.75
- CRESEMBA (Drug) $109.80
- ZERBAXA (Drug) $101.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Dallas
Dr. Ali Bagheri, Md, MD
Hospitalist — Payments: $11,446
Hospitalist $11,446
Janae' Richard
Hospitalist — Payments: $9,928
Hospitalist $9,928
Dr. Anita Khetan, M.d, M.D
Hospitalist — Payments: $9,685
Hospitalist $9,685
Rainer Khetan, M.d, M.D
Hospitalist — Payments: $8,606
Hospitalist $8,606
Amy Gates, Md, MD
Hospitalist — Payments: $6,891
Hospitalist $6,891
Akua Fordjour, Md, Phd, MD, PHD
Hospitalist — Payments: $6,705
Hospitalist $6,705